Closing Figures: Esperion Therapeutics Inc (ESPR)’s Negative Finish at 3.04, Down -20.63

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $3.83 in the prior trading day, Esperion Therapeutics Inc (NASDAQ: ESPR) closed at $3.04, down -20.63%. In other words, the price has decreased by -$20.63 from its previous closing price. On the day, 13.58 million shares were traded. ESPR stock price reached its highest trading level at $3.89 during the session, while it also had its lowest trading level at $2.97.

Ratios:

Our goal is to gain a better understanding of ESPR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.37 and its Current Ratio is at 1.85.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 19 ’24 when Warren Eric sold 197 shares for $2.17 per share. The transaction valued at 427 led to the insider holds 162,355 shares of the business.

Warren Eric bought 197 shares of ESPR for $427 on Nov 19 ’24. On Oct 17 ’24, another insider, Warren Eric, who serves as the Chief Commercial Officer of the company, sold 107 shares for $2.12 each. As a result, the insider received 227 and left with 162,552 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 754643520 and an Enterprise Value of 723231936. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.03. Its current Enterprise Value per Revenue stands at 2.448 whereas that against EBITDA is 43.84.

Stock Price History:

Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $1.35. The 50-Day Moving Average of the stock is 29.90%, while the 200-Day Moving Average is calculated to be 35.55%.

Shares Statistics:

The stock has traded on average 4.41M shares per day over the past 3-months and 7063640 shares per day over the last 10 days, according to various share statistics. A total of 195.44M shares are outstanding, with a floating share count of 195.06M. Insiders hold about 1.00% of the company’s shares, while institutions hold 65.84% stake in the company. Shares short for ESPR as of 1732838400 were 30492669 with a Short Ratio of 7.09, compared to 1730332800 on 33463960. Therefore, it implies a Short% of Shares Outstanding of 30492669 and a Short% of Float of 15.52.

Most Popular